The search terms were glucagon-like peptide-1, glucagon-like peptide-1 receptor agonist, beinaglutide, dulaglutide, exenatide, semaglutide, liraglutide, type 2 diabetes mellitus, atherosclerosis, atherosclerotic cardiovascular disease, coronary atherosclerosis, stable angina, unstable angina, coronary revascularization, cardiovascular outcome trials, platelet activation, blood glucose, blood pressure, lipids, macrophages, inflammation and oxidative stress alone or in combination
Its also approved to treat moderate to severe obstructive sleep apnea (OSA) in adults with obesity
Three protocols cover most joint pain scenarios
It is still not FDA-approved and still carries uncertainty, but it exists within a medical and pharmacy framework